Skip to main content
News

First Polypill trial in people selected on age alone (50 and over) shows substantial health benefit

Results of a randomised trial carried out by academics at Queen Mary, University of London and published in the journal PLoS One [1] show that a four-component Polypill given to people aged 50 and over to reduce their risk of heart attack and stroke, the most common causes of death worldwide, achieved large reductions in blood cholesterol and blood pressure, the main causes of these two diseases.

Published on:

For media information, contact:

Back to top